Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Markman Update

Hello Ron:

Especially your mentioned missing transparancy of our running business costs us share performace. How could possible new investors get a calucation basis having nothing in hand. I also think, old setlements of customers are based on thier ingrigment. I think Alliacense negotiates infrigments with new customers on thier individual bases because each customer is different.

Best wishes

S402005

Share
New Message
Please login to post a reply